DIFFERENCES IN ABILITY OF CELL-WALL ANTIBIOTICS TO SUPPRESS EMERGENCE OF RIFAMPICIN RESISTANCE IN STAPHYLOCCOCUS-AUREUS

被引:22
作者
ENG, RHK
SMITH, SM
BUCCINI, FJ
CHERUBIN, CE
机构
[1] VET ADM MED CTR, LAB SERV, MICROBIOL SECT, E ORANGE, NJ 07019 USA
[2] BAYLEY SETON HOSP, DEPT MED, STATEN ISL, NY 10304 USA
[3] UNIV MED & DENT NEW JERSEY, DEPT MED, NEWARK, NJ 07103 USA
[4] UNIV MED & DENT NEW JERSEY, DEPT MICROBIOL, NEWARK, NJ 07103 USA
关键词
D O I
10.1093/jac/15.2.201
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:201 / 207
页数:7
相关论文
共 19 条
[1]  
ACAR JF, 1983, REV INFECT DIS, V5, pS502
[2]   RIFAMPIN THERAPY OF STAPHYLOCOCCUS-EPIDERMIDIS - USE IN INFECTIONS FROM INDWELLING ARTIFICIAL DEVICES [J].
ARCHER, GL ;
TENENBAUM, MJ ;
HAYWOOD, HB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (08) :751-753
[3]  
BURE AM, 1975, MED MALADIES INFECT, V5, P156
[4]   STAPHYLOCOCCAL BETA-LACTAMASE AND EFFICACY OF BETA-LACTAM ANTIBIOTICS - INVITRO AND INVIVO EVALUATION [J].
CHAPMAN, SW ;
STEIGBIGEL, RT .
JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (06) :1078-1089
[5]   INOCULUM EFFECT OF NEW BETA-LACTAM ANTIBIOTICS ON PSEUDOMONAS-AERUGINOSA [J].
ENG, RHK ;
SMITH, SM ;
CHERUBIN, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (01) :42-47
[6]  
ENG RHK, 1984, ARCH INTERNAL MED
[7]   STAPHYLOCOCCUS-AUREUS ENDOCARDITIS - COMBINED THERAPY WITH VANCOMYCIN AND RIFAMPIN [J].
FAVILLE, RJ ;
ZASKE, DE ;
KAPLAN, EL ;
CROSSLEY, K ;
SABATH, LD ;
QUIE, PG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (18) :1963-1965
[8]  
GOPAL V, 1976, JAMA-J AM MED ASSOC, V236, P1604, DOI 10.1001/jama.236.14.1604
[9]  
KARCHMER AW, 1983, REV INFECT DIS, V5, pS543
[10]  
LOPITAUX R, 1983, PATHOL BIOL, V31, P442